Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QA59
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.315 |
CLV_PCSK_FUR_1 | 51 | 55 | PF00082 | 0.396 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.429 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.396 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.386 |
CLV_PCSK_PC1ET2_1 | 113 | 115 | PF00082 | 0.429 |
CLV_PCSK_PC1ET2_1 | 31 | 33 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.429 |
DOC_PP1_RVXF_1 | 111 | 118 | PF00149 | 0.347 |
DOC_USP7_UBL2_3 | 43 | 47 | PF12436 | 0.529 |
LIG_14-3-3_CanoR_1 | 60 | 70 | PF00244 | 0.368 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.414 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.417 |
LIG_LIR_Gen_1 | 102 | 111 | PF02991 | 0.383 |
LIG_LIR_Gen_1 | 14 | 21 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 67 | 78 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 102 | 106 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 14 | 18 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 67 | 73 | PF02991 | 0.357 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.330 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.395 |
LIG_WRC_WIRS_1 | 12 | 17 | PF05994 | 0.453 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.404 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.343 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.360 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.458 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.399 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.532 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.471 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.415 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.402 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.347 |
TRG_ER_diArg_1 | 53 | 55 | PF00400 | 0.341 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I757 | Leptomonas seymouri | 86% | 100% |
A0A0S4JEW5 | Bodo saltans | 59% | 100% |
A0A0S4JGL7 | Bodo saltans | 59% | 100% |
A0A1X0P4S9 | Trypanosomatidae | 73% | 100% |
A0A3S7WYU9 | Leishmania donovani | 95% | 100% |
A0A422NBX7 | Trypanosoma rangeli | 70% | 99% |
A4I179 | Leishmania infantum | 95% | 100% |
D0A5G4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 75% | 100% |
E9AXB3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
V5BXM4 | Trypanosoma cruzi | 71% | 98% |